Journals / Dicle Tıp Dergisi / 2009 / Cilt: 36 - Sayı: 2

Hemostatic abnormalities in liver cirrhosis

Karaciğer sirozunda hemostatik bozukluklar

Pages
127–133
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This is also important for identification of liver transplant candidiates earlier.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, 44 patients with liver cirrhosis were investigated for hemostatic parameters.
📊
Key Findings & Data:Patients were classified by Child-Pugh criterion and according to this 4 patients were in Class A, 20 in Class B and 20 in C.
💡
Conclusion & Impact:This is also important for identification of liver transplant candidiates earlier.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, 44 patients with liver cirrhosis were investigated for hemostatic parameters. Patients with spontaneous bacterial peritonitis, hepatocellular carcinoma, hepatorenal syndrome and cholestatic liver diseases were excluded. Patients were classified by Child-Pugh criterion and according to this 4 patients were in Class A, 20 in Class B and 20 in C. Regarding to these results, it was aimed to investigate the haematological disturbances in liver cirrhotic patients. In the result there was a correlation between activated partial thromboplastin time, serum iron, ferritin, transferrin, haptoglobin and Child-Pugh classification. Besides there was no correlation between prothrombin time, factor 8 and 9, protein C and S, anti-thrombin 3, fibrinogen, fibrin degradation products, serum iron binding capacity, hemoglobin, leukocyte, mean corpuscular volume and Child-Pugh classification. There were significant difference, in terms of AST, ferritin, haptoglobulin, sex and presence of ascites between groups (p<0.05). In all groups there were abnormalities and dysfunctions in prothrombin time, fibrinogen, factor 8 and 9, serum iron, ferritin, transferrin, haptoglobin, protein C and S, anti-thrombin 3, hemoglobin and platelets, where there was no in activated partial thromboplastin time, fibrin degradation products, serum iron binding capacity, leucocytes and mean corpuscular volume (p>0.05). In the summary, we have found correlation between hemostatic abnormalities and disease activity and clinical prognosis in patients with liver cirrhosis which is important in the management of these patients. This is also important for identification of liver transplant candidiates earlier.

Özet

Hemostatik bozukluklar, karaciğer hastalıklarında sık görülebilmekte ve bazen ciddi sonuçlara yol açabilmektedir. Bu çalışmada protrombin zamanı, aktive parsiyel tromboplastin zamanı, fibrinojen, fibrin yıkım ürünleri, faktör 7, 8 ve 9, transferin, haptoglobin, protein C, protein S, antitrombin III ve diğer bazı hematolojik parametrelerin karaciğer hastalığının düzeyi ile ilişkisi araştırılmıştır. Bu sonuçlara bağlı olarak karaciğer sirozlu hastalarda hematolojik bozuklukların ve hemostatik mekanizmalardaki değişikliklerin incelenmesi amaçlanmıştır. Bu çalışmaya karaciğer sirozu tanısı konan 44 hasta alındı. Hastaların 36’sı erkek, 8’i kadındı. Hastaların yaş ortalaması 43.2 yıl (31-76) idi. Spontan bakteriyel peritonit, hepatoselüler karsinoma, hepatorenal sendrom ve kolestatik karaciğer hastalığı olan vakalar çalışmaya alınmadı. Hastalar 4’ü Child A, 20’si Child B, ve 20’si Child C olmak üzere 3 gruba ayrıldı. Yaş ortalaması A grubunda 39, B’de 54, C’de ise 45 yıl idi (p>0.05). Hastaların 40’ında (%90) HBV, 2’sinde HBV+HDV (%5) , 2’sinde ise (%5) alkole bağlı karaciğer sirozu mevcuttu. Gruplar arasında AST, ferritin, haptoglobulin, cinsiyet ve asit varlığı bakımından anlamlı fark mevcuttu (p 0.05). Gruplar arasında protrombin zamanı, faktör 7, 8 ve 9, protein C ve S, antitrombin III, fibrinojen, fibrin yıkım ürünleri, serum demir bağlama kapasitesi, hemoglobin, platelet, lökosit ve ortalama korpüsküler volüm bakımından fark bulunmadı (p>0.05). Sonuç olarak, karaciğer sirozu olan hastalarda hemostatik bozukluklar ile hastalığın aktivitesi ve klinik seyir arasında ilişki olduğu ve bu durumun hastalığın takip ve tedavisinde önemli olduğu söylenebilir.

🔖

Cite This Article

YALÇIN, K., AYYILDIZ, O. (2009). Hemostatic abnormalities in liver cirrhosis. Dicle Tıp Dergisi, Cilt: 36 - Sayı: 2, 127–133. https://ajindex.com/articles/349326

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Poller L. Coagulation abnormalities in liver disease. In: Poller L, ed. Recent advances in blood coagulation. Edinburg Churchill Livingstone 1977; 267-292
  2. Flute PT. Clotting abnormalities in liver disease. In: Popper H, Schaffner F, ed. Vol VI. Progress in liver disease. New York: Grune and Stratton, Inc., 1979; 301-12
  3. Progress report. Haemostatic problems in liver disease. Gut 1986;27: 339-49
  4. Violi F, Ferro D, Basili S, Cimminiello C, et al. Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. Hepatology 1995; 22:96-100
  5. İç Hastalıkları Ders Kitabı II, Hepatoloji, Cerahpaşa Tıp Fakültesi Yayınları, İstanbul 1996: 6
  6. Şentürk H. Karaciğer hastalıkları: Problemlere yönelik bir yaklaşım. İstanbul Beta Basın Yayın Dağıtım AŞ, 1994
  7. D'Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1983; 37: 468-75
  8. Bircher J. Assessment of prognosis in advanced liver disease: to score or to measure, that is the question. Hepatology 1986; 6: 1036-37
  9. Vierling JM. Epidemiology and clinical courses of liver disease: identification of candidates for liver trnaplantation. Hepatology 1984; 4: 84 S-94S
  10. İç Hastalıkları Ders Kitabı II, Hepatoloji, İstanbul 1996: 8-17
  11. Piqueras B, Banares R, Rincon D, et al. Predictive factors of the mortality of digestive hemorrhage caused by esophageal varices in elderly patients Gastroenterol Hepatol 2011;24: 51-55
  12. Caraceni P, Van Thiel DH. Acute liver failure. Lancet 1995; 345:163-69
  13. Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology 1996; 24: 1392-94
  14. Mindrum G, Glueck HI. Plasma protrombin in liver disease: its clinical and prognostic significance. Ann Intern Med 1959; 50: 1370-83
  15. Manzano ML, Arocena C, Tomas JF, Hedner U, Quiroga JA, Carreno V. Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk. Blood Coagul Fibrinolysis 2000;1:95-9
  16. Wantz GE, Payne MA. Experience with portocaval shunt for portal hypertension. New Engl J Med 1961; 265: 721-28
  17. Turcotte JG, Lambert MJ. Variceal hemorrhage, hepatic cirrhosis, and portal portocaval shunts. Surgery 1973; 73: 810-17
  18. Ballmer PE, Reichen J, McNurlan MA, Sterchi AB, Anderson SE, Garlick PJ. Albumin but not fi